Literature DB >> 24457296

Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Irene L Katzan, John Spertus, Janet Prvu Bettger, Dawn M Bravata, Mathew J Reeves, Eric E Smith, Cheryl Bushnell, Randall T Higashida, Judith A Hinchey, Robert G Holloway, George Howard, Rosemarie B King, Harlan M Krumholz, Barbara J Lutz, Robert W Yeh.   

Abstract

BACKGROUND AND
PURPOSE: Stroke is the fourth-leading cause of death and a leading cause of long-term major disability in the United States. Measuring outcomes after stroke has important policy implications. The primary goals of this consensus statement are to (1) review statistical considerations when evaluating models that define hospital performance in providing stroke care; (2) discuss the benefits, limitations, and potential unintended consequences of using various outcome measures when evaluating the quality of ischemic stroke care at the hospital level; (3) summarize the evidence on the role of specific clinical and administrative variables, including patient preferences, in risk-adjusted models of ischemic stroke outcomes; (4) provide recommendations on the minimum list of variables that should be included in risk adjustment of ischemic stroke outcomes for comparisons of quality at the hospital level; and (5) provide recommendations for further research. METHODS AND
RESULTS: This statement gives an overview of statistical considerations for the evaluation of hospital-level outcomes after stroke and provides a systematic review of the literature for the following outcome measures for ischemic stroke at 30 days: functional outcomes, mortality, and readmissions. Data on outcomes after stroke have primarily involved studies conducted at an individual patient level rather than a hospital level. On the basis of the available information, the following factors should be included in all hospital-level risk-adjustment models: age, sex, stroke severity, comorbid conditions, and vascular risk factors. Because stroke severity is the most important prognostic factor for individual patients and appears to be a significant predictor of hospital-level performance for 30-day mortality, inclusion of a stroke severity measure in risk-adjustment models for 30-day outcome measures is recommended. Risk-adjustment models that do not include stroke severity or other recommended variables must provide comparable classification of hospital performance as models that include these variables. Stroke severity and other variables that are included in risk-adjustment models should be standardized across sites, so that their reliability and accuracy are equivalent. There is a pressing need for research in multiple areas to better identify methods and metrics to evaluate outcomes of stroke care.
CONCLUSIONS: There are a number of important methodological challenges in undertaking risk-adjusted outcome comparisons to assess the quality of stroke care in different hospitals. It is important for stakeholders to recognize these challenges and for there to be a concerted approach to improving the methods for quality assessment and improvement.

Entities:  

Keywords:  AHA Scientific Statements; health policy; outcomes; stroke

Mesh:

Year:  2014        PMID: 24457296     DOI: 10.1161/01.str.0000441948.35804.77

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  Stroke Performance Measures Do Not Predict Functional Outcome.

Authors:  Eric E Adelman; Lynda D Lisabeth; Melinda A Smith; Jonggyu Baek; Erin C Case; Brisa N Sánchez; James F Burke; Lesli E Skolarus; Darin B Zahuranec; William J Meurer; Devin L Brown; Kevin A Kerber; Deborah A Levine; Nelda M Garcia; Morgan S Campbell; Lewis B Morgenstern
Journal:  Neurohospitalist       Date:  2016-10-26

2.  Are There Disparities in Thrombolytic Treatment and Mortality in Acute Ischemic Stroke in the Hispanic Population Living in Border States versus Nonborder States?

Authors:  Ameer E Hassan; David H Kassel; Malik M Adil; Wondwossen G Tekle; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2016-10

3.  [Polymorphism of brain derived neurotrophic factor and recovery of functions after ischemic stroke].

Authors:  J Liepert; A Heller; G Behnisch; A Schoenfeld
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

4.  Identifying Performance Outliers for Stroke Care Based on Composite Score of Process Indicators: an Observational Study in China.

Authors:  Chao Wang; Shaofei Su; Xi Li; Jingkun Li; Xiaoqiang Bao; Meina Liu
Journal:  J Gen Intern Med       Date:  2020-05-27       Impact factor: 5.128

5.  Picking the good apples: statistics versus good judgment in choosing stent operators for a multicenter clinical trial.

Authors:  George Howard; Jenifer H Voeks; James F Meschia; Virginia J Howard; Thomas G Brott
Journal:  Stroke       Date:  2014-09-11       Impact factor: 7.914

6.  Population Health Indicators Associated with a Statewide Telestroke Program.

Authors:  Annie N Simpson; Jillian B Harvey; Steven M DiLembo; Ellen Debenham; Christine A Holmstedt; Cory O Robinson; Kit N Simpson; Eyad Almallouhi; Dee W Ford
Journal:  Telemed J E Health       Date:  2020-02-11       Impact factor: 3.536

7.  Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage.

Authors:  Alessandro Biffi; Joji B Kuramatsu; Audrey Leasure; Hooman Kamel; Christina Kourkoulis; Kristin Schwab; Alison M Ayres; Jordan Elm; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Christopher D Anderson; Stefan Schwab; Jonathan Rosand; Fernando D Testai; Daniel Woo; Hagen B Huttner; Kevin N Sheth
Journal:  Ann Neurol       Date:  2017-10-31       Impact factor: 10.422

8.  Validation and comparison of two stroke prognostic models for in hospital, 30-day and 90-day mortality.

Authors:  Dipankar Dutta; Abigail Cannon; Emily Bowen
Journal:  Eur Stroke J       Date:  2017-03-30

9.  GISCOME - Genetics of Ischaemic Stroke Functional Outcome network: A protocol for an international multicentre genetic association study.

Authors:  Jane M Maguire; Steve Bevan; Tara M Stanne; Erik Lorenzen; Israel Fernandez-Cadenas; Graeme J Hankey; Jordi Jimenez-Conde; Katarina Jood; Jin-Moo Lee; Robin Lemmens; Christopher Levi; Bo Norrving; Kristiina Rannikmae; Natalia Rost; Jonathan Rosand; Peter M Rothwell; Rodney Scott; Daniel Strbian; Jonathan Sturm; Cathie Sudlow; Matthew Traylor; Vincent Thijs; Turgut Tatlisumak; Tadeusz Wieloch; Daniel Woo; Bradford B Worrall; Christina Jern; Arne Lindgren
Journal:  Eur Stroke J       Date:  2017-04-19

10.  Disparities in outcomes associated with rural-urban insurance status in China among inpatient women with stroke: a registry-based cohort study.

Authors:  Hong-Qiu Gu; Xin Yang; Zhen-Zhen Rao; Chun-Juan Wang; Xing-Quan Zhao; Yi-Long Wang; Li-Ping Liu; Chelsea Liu; Hao Li; Zi-Xiao Li; Yong-Jun Wang
Journal:  Ann Transl Med       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.